ImpediMed Future Growth

How is ImpediMed forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


78.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

ASX:IPD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202568816111
6/30/202440-5-4-52
6/30/202323-14-18-122
6/30/202211-20-21-16N/A
3/31/202210-20-19-14N/A
12/31/202110-19-17-13N/A
9/30/20219-20-16-13N/A
6/30/20218-21-16-13N/A
3/31/20217-20-17-15N/A
12/31/20206-19-18-16N/A
9/30/20206-20-20-18N/A
6/30/20206-21-21-19N/A
12/31/20195-25-22-20N/A
9/30/20195-24-22-20N/A
6/30/20194-24-22-20N/A
12/31/20184-25-23-21N/A
9/30/20183-26-24-22N/A
6/30/20183-27-25-23N/A
3/31/20184-28N/AN/AN/A
12/31/20174-28-26-26N/A
9/30/20175-28-26-26N/A
6/30/20176-28-26-26N/A
3/31/20176-28-25-25N/A
12/31/20166-29-25-25N/A
9/30/20166-27-24-24N/A
6/30/20166-26-23-22N/A
3/31/20166-23N/A-19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IPD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: IPD is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IPD is expected to become profitable in the next 3 years.

Revenue vs Market: IPD's revenue (53.1% per year) is forecast to grow faster than the Australian market (3.5% per year).

High Growth Revenue: IPD's revenue (53.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IPD's Return on Equity is forecast to be low in 3 years time (15.7%).


Discover growth companies